30.11.2015 Views

Global Celiac Disease Clinical Trials Review Market Growth and Trend to 2015 Radiant Insights, Inc

Summary Radiant Insights's clinical trial report, "Celiac Disease Global Clinical Trials Review, H1, 2015" provides data on the Celiac Disease clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Celiac Disease. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Celiac Disease. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Radiant Insights's team of industry experts. View Full Report with TOC @ http://www.radiantinsights.com/research/celiac-disease-global-clinical-trials-review-h1-2015 Scope - Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type - Listings of discontinued trials (suspended, withdrawn and terminated) Reason to Buy - Understand the dynamics of a particular indication in a condensed manner - Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more - Obtain discontinued trial listing for trials across the globe - Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Summary

Radiant Insights's clinical trial report, "Celiac Disease Global Clinical Trials Review, H1, 2015" provides data on the Celiac Disease clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Celiac Disease. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Celiac Disease. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Radiant Insights's team of industry experts.

View Full Report with TOC @ http://www.radiantinsights.com/research/celiac-disease-global-clinical-trials-review-h1-2015

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each

- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type

- Listings of discontinued trials (suspended, withdrawn and terminated)

Reason to Buy

- Understand the dynamics of a particular indication in a condensed manner

- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more

- Obtain discontinued trial listing for trials across the globe

- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

<strong>Global</strong> <strong>Celiac</strong> <strong>Disease</strong> <strong>Clinical</strong> <strong>Trials</strong> <strong>Review</strong> <strong>Market</strong> <strong>Growth</strong> <strong>and</strong><br />

<strong>Trend</strong> <strong>to</strong> <strong>2015</strong>: <strong>Radiant</strong> <strong>Insights</strong>, <strong>Inc</strong><br />

Summary<br />

<strong>Radiant</strong> <strong>Insights</strong>'s clinical trial report, "<strong>Celiac</strong> <strong>Disease</strong> <strong>Global</strong> <strong>Clinical</strong> <strong>Trials</strong> <strong>Review</strong>, H1, <strong>2015</strong>"<br />

provides data on the <strong>Celiac</strong> <strong>Disease</strong> clinical trial scenario. This report provides elemental information<br />

<strong>and</strong> data relating <strong>to</strong> the clinical trials on <strong>Celiac</strong> <strong>Disease</strong>. It includes an overview of the trial numbers<br />

<strong>and</strong> their recruitment status as per the site of trial conduction across the globe. The databook offers a<br />

preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors<br />

<strong>and</strong> also provides briefing pertaining <strong>to</strong> the number of trials for the key drugs for treating <strong>Celiac</strong><br />

<strong>Disease</strong>. This report is built using data <strong>and</strong> information sourced from proprietary databases, primary<br />

<strong>and</strong> secondary research <strong>and</strong> in-house analysis by <strong>Radiant</strong> <strong>Insights</strong>'s team of industry experts.<br />

View Full Report with TOC @ http://www.radiantinsights.com/research/celiac-disease-globalclinical-trials-review-h1-<strong>2015</strong><br />

Scope<br />

- Data on the number of clinical trials conducted in North America, South <strong>and</strong> Central America,<br />

Europe, Middle-East <strong>and</strong> Africa <strong>and</strong> Asia-pacific <strong>and</strong> <strong>to</strong>p five national contributions in each<br />

- <strong>Clinical</strong> trial (complete <strong>and</strong> in progress) data by phase, trial status, subjects recruited <strong>and</strong> sponsor<br />

type<br />

- Listings of discontinued trials (suspended, withdrawn <strong>and</strong> terminated)<br />

Reason <strong>to</strong> Buy<br />

- Underst<strong>and</strong> the dynamics of a particular indication in a condensed manner<br />

- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor<br />

type <strong>and</strong> many more<br />

- Obtain discontinued trial listing for trials across the globe<br />

- Espy the commercial l<strong>and</strong>scape of the major Universities / Institutes / Hospitals or Companies<br />

Table of Contents<br />

Table of Contents 2<br />

List of Tables 4<br />

List of Figures 5<br />

Introduction 6


<strong>Celiac</strong> <strong>Disease</strong> 6<br />

Report Guidance 6<br />

<strong>Clinical</strong> <strong>Trials</strong> by Region 7<br />

<strong>Clinical</strong> <strong>Trials</strong> <strong>and</strong> Average Enrollment by Country 8<br />

Top Countries Contributing <strong>to</strong> <strong>Clinical</strong> <strong>Trials</strong> in Asia-Pacific 10<br />

Top Five Countries Contributing <strong>to</strong> <strong>Clinical</strong> <strong>Trials</strong> in Europe 11<br />

Top Countries Contributing <strong>to</strong> <strong>Clinical</strong> <strong>Trials</strong> in North America 12<br />

Top Countries Contributing <strong>to</strong> <strong>Clinical</strong> <strong>Trials</strong> in Middle East <strong>and</strong> Africa 13<br />

Top Countries Contributing <strong>to</strong> <strong>Clinical</strong> <strong>Trials</strong> in Central <strong>and</strong> South America 14<br />

<strong>Clinical</strong> <strong>Trials</strong> by G7 Countries: Proportion of <strong>Celiac</strong> <strong>Disease</strong> <strong>to</strong> Gastrointestinal <strong>Clinical</strong> <strong>Trials</strong> 15<br />

<strong>Clinical</strong> <strong>Trials</strong> by Phase in G7 Countries 16<br />

<strong>Clinical</strong> <strong>Trials</strong> in G7 Countries by Trial Status 17<br />

View Full Report with TOC @ http://www.radiantinsights.com/research/celiac-disease-globalclinical-trials-review-h1-<strong>2015</strong><br />

<strong>Clinical</strong> <strong>Trials</strong> by E7 Countries: Proportion of <strong>Celiac</strong> <strong>Disease</strong> <strong>to</strong> Gastrointestinal <strong>Clinical</strong> <strong>Trials</strong> 18<br />

<strong>Clinical</strong> <strong>Trials</strong> by Phase 19<br />

In Progress <strong>Trials</strong> by Phase 20<br />

<strong>Clinical</strong> <strong>Trials</strong> by Trial Status 21<br />

<strong>Clinical</strong> <strong>Trials</strong> by End Point Status 22<br />

Unaccomplished <strong>Trials</strong> of <strong>Celiac</strong> <strong>Disease</strong> 23<br />

Subjects Recruited Over a Period of Time 24<br />

<strong>Clinical</strong> <strong>Trials</strong> by Sponsor Type 25<br />

Prominent Sponsors 26<br />

Top Companies Participating in <strong>Celiac</strong> <strong>Disease</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> 27<br />

Prominent Drugs 28<br />

<strong>Clinical</strong> Trial Profiles 29<br />

<strong>Clinical</strong> Trial Overview of Top Companies 29<br />

Alba Therapeutics Corporation 29


<strong>Clinical</strong> Trial Overview of Alba Therapeutics Corporation 29<br />

ImmusanT, <strong>Inc</strong>. 30<br />

<strong>Clinical</strong> Trial Overview of ImmusanT, <strong>Inc</strong>. 30<br />

Alvine Pharmaceuticals, <strong>Inc</strong>. 31<br />

<strong>Clinical</strong> Trial Overview of Alvine Pharmaceuticals, <strong>Inc</strong>. 31<br />

Royal DSM N.V. 32<br />

<strong>Clinical</strong> Trial Overview of Royal DSM N.V. 32<br />

Parexel International Corporation 33<br />

<strong>Clinical</strong> Trial Overview of Parexel International Corporation 33<br />

BioLineRx, Ltd. 34<br />

<strong>Clinical</strong> Trial Overview of BioLineRx, Ltd. 34<br />

View Full Report with TOC @ http://www.radiantinsights.com/research/celiac-disease-globalclinical-trials-review-h1-<strong>2015</strong><br />

Meda AB 35<br />

<strong>Clinical</strong> Trial Overview of Meda AB 35<br />

InVentiv Group Holdings, <strong>Inc</strong>. 36<br />

<strong>Clinical</strong> Trial Overview of InVentiv Group Holdings, <strong>Inc</strong>. 36<br />

ChemoCentryx, <strong>Inc</strong>. 37<br />

<strong>Clinical</strong> Trial Overview of ChemoCentryx, <strong>Inc</strong>. 37<br />

Calypso Biotech SA 38<br />

<strong>Clinical</strong> Trial Overview of Calypso Biotech SA 38<br />

<strong>Clinical</strong> Trial Overview of Top Institutes / Government 39<br />

All India Institute of Medical Sciences 39<br />

<strong>Clinical</strong> Trial Overview of All India Institute of Medical Sciences 39<br />

Beth Israel Deaconess Medical Center, <strong>Inc</strong>. 40<br />

<strong>Clinical</strong> Trial Overview of Beth Israel Deaconess Medical Center, <strong>Inc</strong>. 40<br />

Maastricht University Medical Center 41<br />

<strong>Clinical</strong> Trial Overview of Maastricht University Medical Center 41


Shaare Zedek Medical Center 42<br />

<strong>Clinical</strong> Trial Overview of Shaare Zedek Medical Center 42<br />

Azienda Ospedaliera Spedali Civili di Brescia 43<br />

<strong>Clinical</strong> Trial Overview of Azienda Ospedaliera Spedali Civili di Brescia 43<br />

Columbia University 44<br />

<strong>Clinical</strong> Trial Overview of Columbia University 44<br />

Dr. C. Bonorino Udaondo Gastroenterology Hospital 45<br />

<strong>Clinical</strong> Trial Overview of Dr. C. Bonorino Udaondo Gastroenterology Hospital 45<br />

Heim Pal Children's Hospital 46<br />

<strong>Clinical</strong> Trial Overview of Heim Pal Children's Hospital 46<br />

Indian Council of Medical Research 47<br />

View Full Report with TOC @ http://www.radiantinsights.com/research/celiac-disease-globalclinical-trials-review-h1-<strong>2015</strong><br />

<strong>Clinical</strong> Trial Overview of Indian Council of Medical Research 47<br />

Joslin Diabetes Center 48<br />

<strong>Clinical</strong> Trial Overview of Joslin Diabetes Center 48<br />

Five Key <strong>Clinical</strong> Profiles 49<br />

Appendix 77<br />

Abbreviations 77<br />

Definitions 77<br />

Research Methodology 78<br />

Secondary Research 78<br />

About <strong>Global</strong>Data 79<br />

Contact Us 79<br />

Disclaimer 79<br />

Source 79<br />

List of Tables


<strong>Celiac</strong> <strong>Disease</strong> Therapeutics, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Region, <strong>2015</strong>* 7<br />

<strong>Celiac</strong> <strong>Disease</strong> Therapeutics, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> <strong>and</strong> Average Enrollment by Top Countries,<br />

<strong>2015</strong>* 8<br />

<strong>Celiac</strong> <strong>Disease</strong> Therapeutics, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> In Progress by Top Countries, <strong>2015</strong>* 9<br />

<strong>Celiac</strong> <strong>Disease</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong>, Asia-Pacific, Top Countries, <strong>2015</strong>* 10<br />

<strong>Celiac</strong> <strong>Disease</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong>, Europe, Top Five Countries, <strong>2015</strong>* 11<br />

<strong>Celiac</strong> <strong>Disease</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong>, North America, Top Countries, <strong>2015</strong>* 12<br />

<strong>Celiac</strong> <strong>Disease</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong>, Middle East <strong>and</strong> Africa, Top Countries, <strong>2015</strong>* 13<br />

<strong>Celiac</strong> <strong>Disease</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong>, Central <strong>and</strong> South America, Top Countries, <strong>2015</strong>* 14<br />

Proportion of <strong>Celiac</strong> <strong>Disease</strong> <strong>to</strong> Gastrointestinal <strong>Clinical</strong> <strong>Trials</strong>, G7 Countries (%), <strong>2015</strong>* 15<br />

<strong>Celiac</strong> <strong>Disease</strong> Therapeutics, G7 Countries, <strong>Clinical</strong> <strong>Trials</strong> by Phase, <strong>2015</strong>* 16<br />

<strong>Celiac</strong> <strong>Disease</strong> Therapeutics, G7 Countries, <strong>Clinical</strong> <strong>Trials</strong> by Trial Status, <strong>2015</strong>* 17<br />

View Full Report with TOC @ http://www.radiantinsights.com/research/celiac-disease-globalclinical-trials-review-h1-<strong>2015</strong><br />

Proportion of <strong>Celiac</strong> <strong>Disease</strong> <strong>to</strong> Gastrointestinal <strong>Clinical</strong> <strong>Trials</strong>, E7 Countries (%), <strong>2015</strong>* 18<br />

<strong>Celiac</strong> <strong>Disease</strong> Therapeutics, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Phase, <strong>2015</strong>* 19<br />

<strong>Celiac</strong> <strong>Disease</strong> Therapeutics, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> In Progress by Phase <strong>2015</strong>* 20<br />

<strong>Celiac</strong> <strong>Disease</strong> Therapeutics, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Trial Status, <strong>2015</strong>* 21<br />

<strong>Celiac</strong> <strong>Disease</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong>, <strong>Global</strong>, by End Point Status, <strong>2015</strong>* 22<br />

<strong>Celiac</strong> <strong>Disease</strong> Therapeutics, <strong>Global</strong>, Terminated <strong>Clinical</strong> <strong>Trials</strong>, <strong>2015</strong>* 23<br />

<strong>Celiac</strong> <strong>Disease</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong>, <strong>Global</strong>, Average Enrollment Target <strong>Trend</strong>s, 2010-2014<br />

24<br />

<strong>Celiac</strong> <strong>Disease</strong> Therapeutics <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Sponsor Type, <strong>2015</strong>* 25<br />

<strong>Celiac</strong> <strong>Disease</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong>, <strong>Global</strong>, Key Sponsors, <strong>2015</strong>* 26<br />

<strong>Celiac</strong> <strong>Disease</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong>, <strong>Global</strong>, Top Companies by Phase, <strong>2015</strong>* 27<br />

<strong>Celiac</strong> <strong>Disease</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong>, <strong>Global</strong>, Ongoing <strong>Clinical</strong> <strong>Trials</strong> by Prominent Drugs,<br />

<strong>2015</strong>* 28<br />

<strong>Celiac</strong> <strong>Disease</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Alba Therapeutics<br />

Corporation, <strong>2015</strong>* 29


<strong>Celiac</strong> <strong>Disease</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by ImmusanT, <strong>Inc</strong>., <strong>2015</strong>*<br />

30<br />

<strong>Celiac</strong> <strong>Disease</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Alvine<br />

Pharmaceuticals, <strong>Inc</strong>., <strong>2015</strong>* 31<br />

<strong>Celiac</strong> <strong>Disease</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Royal DSM N.V.,<br />

<strong>2015</strong>* 32<br />

<strong>Celiac</strong> <strong>Disease</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Parexel International<br />

Corporation, <strong>2015</strong>* 33<br />

<strong>Celiac</strong> <strong>Disease</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by BioLineRx, Ltd., <strong>2015</strong>*<br />

34<br />

<strong>Celiac</strong> <strong>Disease</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Meda AB, <strong>2015</strong>* 35<br />

<strong>Celiac</strong> <strong>Disease</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by InVentiv Group<br />

Holdings, <strong>Inc</strong>., <strong>2015</strong>* 36<br />

<strong>Celiac</strong> <strong>Disease</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by ChemoCentryx, <strong>Inc</strong>.,<br />

<strong>2015</strong>* 37<br />

View Full Report with TOC @ http://www.radiantinsights.com/research/celiac-disease-globalclinical-trials-review-h1-<strong>2015</strong><br />

<strong>Celiac</strong> <strong>Disease</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Calypso Biotech SA,<br />

<strong>2015</strong>* 38<br />

<strong>Celiac</strong> <strong>Disease</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by All India Institute of<br />

Medical Sciences, <strong>2015</strong>* 39<br />

<strong>Celiac</strong> <strong>Disease</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Beth Israel Deaconess<br />

Medical Center, <strong>Inc</strong>., <strong>2015</strong>* 40<br />

<strong>Celiac</strong> <strong>Disease</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Maastricht University<br />

Medical Center, <strong>2015</strong>* 41<br />

<strong>Celiac</strong> <strong>Disease</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Shaare Zedek Medical<br />

Center, <strong>2015</strong>* 42<br />

<strong>Celiac</strong> <strong>Disease</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Azienda Ospedaliera<br />

Spedali Civili di Brescia, <strong>2015</strong>* 43<br />

<strong>Celiac</strong> <strong>Disease</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Columbia University,<br />

<strong>2015</strong>* 44<br />

<strong>Celiac</strong> <strong>Disease</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Dr. C. Bonorino<br />

Udaondo Gastroenterology Hospital, <strong>2015</strong>* 45<br />

<strong>Celiac</strong> <strong>Disease</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Heim Pal Children's<br />

Hospital, <strong>2015</strong>* 46


<strong>Celiac</strong> <strong>Disease</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Indian Council of<br />

Medical Research, <strong>2015</strong>* 47<br />

<strong>Celiac</strong> <strong>Disease</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Joslin Diabetes Center,<br />

<strong>2015</strong>* 48<br />

List of Figures<br />

<strong>Celiac</strong> <strong>Disease</strong> Therapeutics, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Region (%), <strong>2015</strong>* 7<br />

<strong>Celiac</strong> <strong>Disease</strong> Therapeutics, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> <strong>and</strong> Average Enrollment by Top Countries,<br />

<strong>2015</strong>* 8<br />

<strong>Celiac</strong> <strong>Disease</strong> Therapeutics, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> In Progress by Top Countries, <strong>2015</strong>* 9<br />

<strong>Celiac</strong> <strong>Disease</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong>, Asia-Pacific, Top Countries (%), <strong>2015</strong>* 10<br />

<strong>Celiac</strong> <strong>Disease</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong>, Europe, Top Five Countries (%), <strong>2015</strong>* 11<br />

<strong>Celiac</strong> <strong>Disease</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong>, North America, Top Countries (%), <strong>2015</strong>* 12<br />

Proportion of <strong>Celiac</strong> <strong>Disease</strong> <strong>to</strong> Gastrointestinal <strong>Clinical</strong> <strong>Trials</strong>, G7 Countries (%), <strong>2015</strong>* 15<br />

<strong>Celiac</strong> <strong>Disease</strong> Therapeutics, G7 Countries, <strong>Clinical</strong> <strong>Trials</strong> by Phase, <strong>2015</strong>* 16<br />

View Full Report with TOC @ http://www.radiantinsights.com/research/celiac-disease-globalclinical-trials-review-h1-<strong>2015</strong><br />

<strong>Celiac</strong> <strong>Disease</strong> Therapeutics, G7 Countries, <strong>Clinical</strong> <strong>Trials</strong> by Trial Status, <strong>2015</strong>* 17<br />

Proportion of <strong>Celiac</strong> <strong>Disease</strong> <strong>to</strong> Gastrointestinal <strong>Clinical</strong> <strong>Trials</strong>, E7 Countries (%), <strong>2015</strong>* 18<br />

<strong>Celiac</strong> <strong>Disease</strong> Therapeutics, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Phase (%), <strong>2015</strong>* 19<br />

<strong>Celiac</strong> <strong>Disease</strong> Therapeutics, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> In Progress by Phase, <strong>2015</strong>* 20<br />

<strong>Celiac</strong> <strong>Disease</strong> Therapeutics, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Trial Status, <strong>2015</strong>* 21<br />

<strong>Celiac</strong> <strong>Disease</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong>, <strong>Global</strong>, by End Point Status, <strong>2015</strong>* 22<br />

<strong>Celiac</strong> <strong>Disease</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong>, <strong>Global</strong>, Average Enrollment Target <strong>Trend</strong>s, 2010-2014<br />

24<br />

<strong>Celiac</strong> <strong>Disease</strong> Therapeutics <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Sponsor Type (%), <strong>2015</strong>* 25<br />

<strong>Celiac</strong> <strong>Disease</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong>, <strong>Global</strong>, Key Sponsors, <strong>2015</strong>* 26<br />

<strong>Celiac</strong> <strong>Disease</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong>, <strong>Global</strong>, Top Companies by Phase, <strong>2015</strong>* 27<br />

<strong>Celiac</strong> <strong>Disease</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong>, <strong>Global</strong>, Ongoing <strong>Clinical</strong> <strong>Trials</strong> by Prominent Drugs,<br />

<strong>2015</strong>* 28


About <strong>Radiant</strong> <strong>Insights</strong><br />

<strong>Radiant</strong> <strong>Insights</strong> is a platform for companies looking <strong>to</strong> meet their market research <strong>and</strong> business<br />

intelligence requirements. We assist <strong>and</strong> facilitate organizations <strong>and</strong> individuals procure market<br />

research reports, helping them in the decision making process. We have a comprehensive collection of<br />

reports, covering over 40 key industries <strong>and</strong> a host of micro markets. In addition <strong>to</strong> over extensive<br />

database of reports, our experienced research coordina<strong>to</strong>rs also offer a host of ancillary services such<br />

as, research partnerships/ tie-ups <strong>and</strong> cus<strong>to</strong>mized research solutions.<br />

For More Information, Visit <strong>Radiant</strong> <strong>Insights</strong><br />

Contact:<br />

Michelle Thoras<br />

Corporate Sales Specialist, USA<br />

<strong>Radiant</strong> <strong>Insights</strong>, <strong>Inc</strong><br />

Phone: 1-415-349-0054<br />

Toll Free: 1-888-202-9519<br />

Email: sales@radiantinsights.com<br />

Blog URL: http://www.radiantinsightsinc.blogspot.com

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!